3CLD | Transcription | date | Mar 18, 2008 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Ligand Binding Domain Of The Glucocorticoid Receptor Complex Fluticazone Furoate | ||||||||||||||
authors | L.M.Shewchuk, I.Mclay, E.Stewart, K.B.Biggadike, A.M.Hassell, R.K | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Glucocorticoid Receptor Chain: A, B Fragment: Ligand Binding Domain, Unp Residues 521-777 Synonym: Gr, Nuclear Receptor Subfamily 3 Group C Member 1 Engineered: Yes Mutation: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Gene: Nr3c1, Grl Expression_system: Escherichia Coli Expression_system_strain: Bl21 De3 Expression_system_vector_type: Plasmid Expression_system_plasmid: Pet | ||||||||||||||
Molecule: Tif2 Coactivator Motif Chain: H, C Engineered: Yes |
Synthetic: Yes Other_details: The Peptide Was Chemically Synthesized, The Can Be Found In Homo Sapiens (Human) | ||||||||||||||
symmetry | Space Group: P 61 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.84 Å | ||||||||||||
ligand | GW6 BindingDB | enzyme |
| ||||||||||||
Primary reference | X-ray Crystal Structure of the Novel Enhanced-Affinity Glucocorticoid Agonist Fluticasone Furoate in the Glucocorticoid Receptor-Ligand Binding Domain., Biggadike K, Bledsoe RK, Hassell AM, Kirk BE, McLay IM, Shewchuk LM, Stewart EL, J Med Chem. 2008 Jun 26;51(12):3349-52. Epub 2008 Jun 4. PMID:18522385 |
Data retrieval |
View 3CLD in 3D |
Visual 3D analysis of 3CLD |
Structure-derived information |
Sequence-derived information |
Other resources with information on 3CLD |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |